A scandal rocks India’s pharmaceutical industry
Can the world’s pharmacy escape a reputation for poor quality control?
It is the stuff of parental nightmares. Between July and October 70 children in Gambia died of kidney failure. In December 18 perished in Uzbekistan from renal problems and acute respiratory disease. In both cases Indian-made cough syrups may have been at fault, according to allegations by a Gambian parliamentary committee and the Uzbek authorities.
This article appeared in the Business section of the print edition under the headline “A bitter syrup”
From the January 7th 2023 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
Meet the ambitious wolf cubs of Wall Street
A duo of whippersnappers is taking on Goldman Sachs
What next for US Steel?
The faded industrial icon has few good options without a Nippon deal
Foxconn and other gadget-makers are expanding their empires
The world’s contract manufacturers are moving into new products and places
The signals of workplace submissiveness
Deference is all around you, unfortunately
America’s internet giants are being outplayed in the global south
From e-commerce to online banking, regional competitors are innovating rapidly
Will Mark Zuckerberg’s Trump gamble pay off?
He risks making enemies elsewhere